Sees FY23 revenue $5.7B-$5.8B, consensus $5.65B. Xylem’s full-year and first quarter 2023 guidance does not reflect the planned acquisition of Evoqua, which was announced on January 23, 2023, and is expected to close mid-year 2023.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on XYL:
- Evoqua Water downgraded on pending takeout at RBC Capital
- Evoqua Water downgraded to Neutral from Outperform at Baird
- Xylem-Evoqua deal timing a surprise, but not tie-up, says Morgan Stanley
- Xylem deal for Evoqua priced ‘high’ but ‘great’ long-term fit, says Loop Capital
- Xylem upgraded to Buy from Hold at Stifel
